Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Assets Average (2016 - 2026)

Ironwood Pharmaceuticals' Assets Average history spans 15 years, with the latest figure at $396.5 million for Q4 2025.

  • On a quarterly basis, Assets Average rose 7.1% to $396.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $396.5 million, a 7.1% increase, with the full-year FY2025 number at $373.9 million, down 9.02% from a year prior.
  • Assets Average hit $396.5 million in Q4 2025 for Ironwood Pharmaceuticals, up from $369.5 million in the prior quarter.
  • Over the last five years, Assets Average for IRWD hit a ceiling of $1.1 billion in Q1 2023 and a floor of $335.1 million in Q2 2025.
  • Historically, Assets Average has averaged $694.3 million across 5 years, with a median of $571.5 million in 2021.
  • Biggest five-year swings in Assets Average: skyrocketed 122.96% in 2021 and later tumbled 59.66% in 2024.
  • Tracing IRWD's Assets Average over 5 years: stood at $1.1 billion in 2021, then dropped by 2.97% to $1.1 billion in 2022, then tumbled by 53.52% to $497.6 million in 2023, then dropped by 25.6% to $370.2 million in 2024, then grew by 7.1% to $396.5 million in 2025.
  • Business Quant data shows Assets Average for IRWD at $396.5 million in Q4 2025, $369.5 million in Q3 2025, and $335.1 million in Q2 2025.